Promoter holding
64.27%
AI
Adcock Ingram Limited - Due diligence report
A 360° intelligence report on Adcock Ingram: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Adcock Ingram — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Adcock Ingram is assessed as Low Risk with a Trust Score of 82/100. Adcock Ingram is an active public limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 01 Aug 2026 from the latest processed filings. Adcock Ingram Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A1).
Charges position: 1 open (27.50 cr) · 1 satisfied (84.45 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of Hyderabad | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PRAVIN VAIDYANATHAN IYER | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALOK SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANDRA MOHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PANKAJ GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YASUHIRO NAKAGIRI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHANTHAKUMARIE PATHER | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMMANNA CHOWDARY YARLAGADDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YUDHVEER SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KENSHI MURASE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KENSUKE HATA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DORETTE NEETHLING | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 11 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
2
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Adcock Ingram Pharma Private Limited | Subsidiary Company | 74.00% |
| Medreich Limited | Joint Ventures | 74.00% |
| Adcock Ingram Holdings (pty) Ltd | Joint Ventures | 74.00% |
Key managerial personnel: CHANDRA MOHAN (CFO) · AMMANNA CHOWDARY YARLAGADDA (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 65
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Net margin improved to 1.42.
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 director exits within 2 years.
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 27.50 cr already registered.
- Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events29 Sep 2025
Last AGM held
Annual general meeting
28 Sep 2025
Director ceased
DORETTE NEETHLING
31 Mar 2025
Latest balance sheet
Filed with ROC
19 Feb 2025
Director appointed
DORETTE NEETHLING (Director)
12 Feb 2025
Director ceased
SHANTHAKUMARIE PATHER
27 Sep 2024
Director ceased
YASUHIRO NAKAGIRI
08 May 2024
Director appointed
YASUHIRO NAKAGIRI (Director)
02 Aug 2023
Director appointed
CHANDRA MOHAN (CFO)
28 Sep 2022
Director appointed
SHANTHAKUMARIE PATHER (Director)
Director ceased
YUDHVEER SINGH
Director ceased
KENSUKE HATA
21 Sep 2022
Director appointed
AMMANNA CHOWDARY YARLAGADDA (Managing Director)
Director ceased
AMMANNA CHOWDARY YARLAGADDA
21 Jun 2022
Director appointed
ALOK SHARMA (Company Secretary)
Director appointed
KENSUKE HATA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
11 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A1 from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Pelgel | L24110TG1980PLC002633 | Secunderabad, Andhra Pradesh, India |
| Recipharm | U24230MH2015PTC440983 | Mumbai, Maharashtra, India |
| R M Phosphates & Chemicals Private Limited | U24100MH2010PTC208728 | Mumbai, Maharashtra, India |
| Nahar Colours And Coating Private Limited | U24114GJ1985PTC128502 | Bharuch, Gujarat, India |
| Sigachi | L24110TG1989PLC009497 | Hyderabad, Telangana, India |
| Halewood Laboratories | U24231GJ2000PTC038236 | Ahmedabad, Gujarat, India |
| Olon | U24100MH2018FTC314115 | Thane, Maharashtra, India |
| Sgf Industries Private Limited | U15117DL2016PTC307946 | Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Adcock Ingram before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Adcock Ingram: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Adcock Ingram - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Adcock Ingram pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Adcock Ingram - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Adcock Ingram an active company?
Adcock Ingram has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Adcock Ingram financially healthy?
Adcock Ingram has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.
Should I do business with Adcock Ingram?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Adcock Ingram?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 11 active director(s) are on record.
Does Adcock Ingram have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.
Is Adcock Ingram up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Adcock Ingram?
Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
